Literature DB >> 26778224

Research advances in traditional Chinese medicine syndromes in cancer patients.

Qing Ji1,2, Yun-quan Luo3, Wen-hai Wang4, Xuan Liu2, Qi Li2, Shi-bing Su1.   

Abstract

Traditional Chinese medicine (TCM) syndrome, also known as TCM ZHENG or TCM pattern, is an integral and essential part of TCM theory that helps to guide the design of individualized treatments. A TCM syndrome, in essence, is a characteristic profile of all clinical manifestations in one patient that can be readily identified by a TCM practitioner. In this article, the authors reviewed the presentations of TCM syndromes in seven common malignancies (liver, lung, gastric, breast, colorectal, pancreatic and esophageal cancers), the objectivity and the standardization of TCM syndrome differentiation, the evaluation of TCM syndrome modeling in cancer research, and syndrome differentiation-guided TCM treatment of cancers. A better understanding of TCM syndrome theory, as well as its potential biological basis, may contribute greatly to the clinical TCM diagnosis and the treatment of cancer.

Entities:  

Mesh:

Year:  2016        PMID: 26778224     DOI: 10.1016/S2095-4964(16)60237-6

Source DB:  PubMed          Journal:  J Integr Med


  21 in total

Review 1.  Evidence-Based Dampness-Heat ZHENG (Syndrome) in Cancer: Current Progress toward Establishing Relevant Animal Model with Pancreatic Tumor.

Authors:  Ju-Ying Jiao; Chien-Shan Cheng; Zhang-Qi Cao; Lian-Yu Chen; Zhen Chen
Journal:  Chin J Integr Med       Date:  2022-06-20       Impact factor: 1.978

2.  Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia.

Authors:  Honglei Tu; Bo Lei; Shan Meng; Hailing Liu; Yongchang Wei; Aili He; Wanggang Zhang; Fuling Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-21       Impact factor: 2.629

Review 3.  Salvianolate injection in the treatment of unstable angina pectoris: A systematic review and meta-analysis.

Authors:  Dan Zhang; Jiarui Wu; Shi Liu; Xiaomeng Zhang; Bing Zhang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

4.  Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells.

Authors:  Lei Shen; Shan-Qiang Zhang; Lei Liu; Yu Sun; Yu-Xuan Wu; Li-Ping Xie; Ji-Cheng Liu
Journal:  Med Sci Monit       Date:  2017-01-14

5.  Characteristic proteins in the plasma of postoperative colorectal and liver cancer patients with Yin deficiency of liver-kidney syndrome.

Authors:  Qing Ji; Wenhai Wang; Yunquan Luo; Feifei Cai; Yiyu Lu; Wanli Deng; Qi Li; Shibing Su
Journal:  Oncotarget       Date:  2017-10-11

6.  CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma.

Authors:  Du-Chu Chen; You-De Liang; Liang Peng; Yi-Ze Wang; Chun-Zhi Ai; Xin-Xing Zhu; Ya-Wei Yan; Yasmeen Saeed; Bin Yu; Jingying Huang; Yuxin Gao; Jiaqi Liu; Yi-Zhou Jiang; Min Liu; Demeng Chen
Journal:  Cancer Cell Int       Date:  2017-11-14       Impact factor: 5.722

7.  National survey of China's oncologists' knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine.

Authors:  Geliang Yang; Richard Lee; Huiqing Zhang; Wei Gu; Peiying Yang; Changquan Ling
Journal:  Oncotarget       Date:  2017-02-21

8.  A Survey of Licensed Acupuncturists in the San Francisco Bay Area: Prevalence of Treating Oncology Patients.

Authors:  Donald Abrams; Michael McCulloch; Misha Cohen; Mike Liaw; Deborah Silverman; Carla Wilson
Journal:  Integr Cancer Ther       Date:  2017-01-05       Impact factor: 3.279

9.  MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm.

Authors:  Lei Wang; Jianming Zheng; Chang Sun; Li Wang; Gang Jin; Lei Xin; Zhendong Jin; Dong Wang; Zhaoshen Li
Journal:  Oncotarget       Date:  2017-05-08

10.  Characteristic Analysis of Complementary and Alternative Medicine in Randomized Controlled Trials of Oncology: A Comparison of Published Studies.

Authors:  Huiqing Zhang; Geliang Yang; Wei Zhang; Wei Gu; Yonghua Su; Changquan Ling
Journal:  Integr Cancer Ther       Date:  2017-03-15       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.